How MAEA Solves the Data Lifecycle Problem
Sizing a medical AI dataset is arithmetic. Keeping that dataset provable, versioned, and reusable across years of development is the part that fails, and it is what MAEA is built to hold together.
ModAstera welcomes Prof. Christian Aldridge, a leading UK dermatologist and skin cancer authority, as Chief Medical Officer to drive clinical governance across Hebra and MAEA.

By ModAstera
02 Mar 2026
We're thrilled to welcome Prof. Christian Aldridge as our Chief Medical Officer.
Prof. Aldridge is a Consultant Dermatologist at Prince Charles Hospital, South Wales, and one of the UK's leading authorities on skin cancer, dermoscopy, and AI-assisted dermatological diagnostics.
Prof. Aldridge has spent his career at the intersection of clinical dermatology, medical education, and diagnostic innovation. His deep expertise in skin cancer detection, dermoscopy, and his active work in AI research make him the ideal clinical leader for ModAstera as we build Hebra, our AI-powered dermatology platform, and continue expanding MAEA - our Medical AI Engineering Agent.
As CMO, he will provide clinical governance across our products, guide AI model validation and safety, shape our dermatologist network, and ensure that everything we build meets the highest standards of clinical accuracy and patient safety.
At ModAstera, we believe the best medical AI is built with clinicians, not just for them. Prof. Aldridge joining our team is a statement of that commitment.
Welcome aboard, Prof. Aldridge.
Learn more about Prof. Aldridge: https://www.christianaldridge.co.uk
Sizing a medical AI dataset is arithmetic. Keeping that dataset provable, versioned, and reusable across years of development is the part that fails, and it is what MAEA is built to hold together.
There is no single number. There is a data budget, a timeline, and an endpoint that finally makes the number computable. A full report on sizing evidence for regulated medical AI.
A practical guide to testing whether a locked medical-AI system transfers beyond its development data, including cohort design, thresholds, subgroup analysis, workflow evaluation, and failure review.